Markets:

Overview

News

Currencies

International

Treasuries

Globus Medical, Inc. Class A Common Stock (NY:GMED)

95.43 +1.60 (+1.71%)

Streaming Delayed Price Updated: 10:04 AM EDT, Apr 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Globus Medical, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Globus Medical Inc - A (NYSE:GMED) Scores High Growth Momentum and Technical Setup Ratings ↗

Today 4:50 EDT

Via Chartmill

2 Cash-Heavy Stocks with Exciting Potential and 1 We Turn Down

April 17, 2026

A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face c...

Via StockStory

2 Reasons to Like GMED and 1 to Stay Skeptical

April 15, 2026

What a fantastic six months it’s been for Globus Medical. Shares of the company have skyrocketed 62.5%, hitting $94.80. This was partly thanks to its solid q...

Via StockStory

2 Profitable Stocks with Promising Prospects and 1 Facing Challenges

April 08, 2026

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...

Via StockStory

Globus Medical Inc (NYSE:GMED): A Prime Affordable Growth Stock with Strong Fundamentals ↗

April 01, 2026

Via Chartmill

Is Stagflation Creeping Into the Picture? ↗

March 29, 2026

GDP data shows an economy that slowed to a crawl in the fourth quarter of 2025 as inflation picked up.

Via The Motley Fool

Globus Medical Inc. (NYSE:GMED) Presents a Compelling Mix of Strong Fundamentals and Technical Setup ↗

March 24, 2026

Via Chartmill

Artivion, Intuitive Surgical, GE HealthCare, LeMaitre, and Globus Medical Shares Plummet, What You Need To Know

March 27, 2026

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...

Via StockStory

Topics Government Stocks

1 Cash-Producing Stock to Target This Week and 2 That Underwhelm

March 17, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

Via StockStory

This Investor Sold $104 Million of Nuvalent Stock Amid Cancer Drug Developer's Nearly 30% Rally ↗

March 16, 2026

Nuvalent develops targeted therapies for drug-resistant cancers, advancing clinical-stage candidates in precision oncology.

Via The Motley Fool

Globus Medical Inc (NYSE:GMED): A GARP Stock with Strong Growth and a Reasonable Price ↗

March 09, 2026

Via Chartmill

Globus Medical Inc (NYSE:GMED) Beats Q4 Estimates and Raises 2026 EPS Guidance ↗

February 24, 2026

Via Chartmill

Globus Medical Inc (NYSE:GMED): A Prime Example of Affordable Growth ↗

February 11, 2026

Via Chartmill

Globus Medical Inc - A (NYSE:GMED) Shows Strong Fundamentals and Technical Setup for Growth ↗

February 03, 2026

Via Chartmill

This Biotech Attracted a $181 Million Investment During a Staggering 1,300% Stock Rally ↗

March 16, 2026

This clinical-stage biotech develops small-molecule therapies targeting NASH, obesity, and related metabolic diseases.

Via The Motley Fool

2 Growth Stocks to Stash and 1 We Turn Down

March 12, 2026

Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market va...

Via StockStory

Topics Economy

3 Healthcare Stocks to Target This Week

March 09, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have se...

Via StockStory

Globus Medical Inc (NYSE:GMED) Emerges as a Minervini-Style Growth Momentum Candidate ↗

January 17, 2026

Via Chartmill

Globus Medical (NYSE:GMED) Delivers Strong Q4 CY2025 Numbers

February 24, 2026

Medical device company Globus Medical (NYSE:GMED) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 25.7% year on year to $826.4 million. The company’s full-year revenue...

Via StockStory

Globus Medical (GMED) Reports Earnings Tomorrow: What To Expect

February 22, 2026

Medical device company Globus Medical (NYSE:GMED) will be reporting results this Tuesday after market close. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence Government World Trade

Inside a $75 Million Albertsons Stock Sale as Shares Sink 8% in a Year ↗

February 20, 2026

Albertsons operates a nationwide grocery network, pairing in-house food production with a broad mix of retail and pharmacy services.

Via The Motley Fool

Topics Regulatory Compliance

AvePoint Stock Down 47% as One Fund Slashes Stake by $65.9 Million ↗

February 20, 2026

This technology firm offers cloud-based data management and compliance tools for organizations using Microsoft 365 and other platforms.

Via The Motley Fool

Topics Regulatory Compliance

Geneva Capital Dumps 95,000 OLLI Shares Worth $11.5 Million ↗

February 13, 2026

This off-price retailer leverages closeout sourcing to deliver brand-name merchandise at value prices across more than 450 U.S. stores.

Via The Motley Fool

Topics Regulatory Compliance

1 Cash-Heavy Stock with Promising Prospects and 2 We Find Risky

February 11, 2026

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.

Via StockStory

2 Reasons to Watch GMED and 1 to Stay Cautious

February 04, 2026

What a fantastic six months it’s been for Globus Medical. Shares of the company have skyrocketed 62.5%, hitting $87.15. This was partly due to its solid quarterly results, and the run-up might have...

Via StockStory

Chart Industries Exit Comes With a $210 Takeout Clock and $6 Billion Backlog ↗

January 29, 2026

Chart Industries supplies cryogenic and heat transfer equipment to energy, industrial gas, and specialty markets worldwide.

Via The Motley Fool

Topics Regulatory Compliance Supply Chain

Knife River Stock Has Tumbled 31% This Past Year, but One Fund Placed a $22 Million Bet on a Turnaround ↗

January 29, 2026

Knife River delivers construction materials and services for large U.S. infrastructure projects, serving both public and private clients.

Via The Motley Fool

1 Safe-and-Steady Stock to Research Further and 2 That Underwhelm

January 28, 2026

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Via StockStory

1 Mooning Stock to Keep an Eye On and 2 Facing Challenges

January 21, 2026

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial...

Via StockStory

Topics Bankruptcy

A Whole Watchlist of “Coiled Springs” (Found With One Simple ChartMill Screen) ↗

January 15, 2026

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.